@article{ref1,
title="Antidepressant use during pregnancy and ADHD risk in children: current knowledge",
journal="British journal of obstetrics and gynaecology: BJOG",
year="2018",
author="Boukhris, Takoua",
volume="125",
number="9",
pages="1085-1085",
abstract="Antidepressants (ADs) are among the most frequently used medications in pregnancy. ADs can cross the placental barrier (Rampono et al. Pharmacopsychiatry 2009;42(3):95-100, Loughhead et al. Biol Psychiatry 2006;59(3):287-90), resulting in a dysfunction of the serotonergic and norepinephrine systems, which could cause inattention or hyperactivity-impulsivity behaviors as exhibited in ADHD. Several epidemiological studies have investigated the potential link between AD exposure during pregnancy and the risk of attention deficit disorder with/without hyperactivity (ADHD) in children. However, findings have been conflicting. This article is protected by copyright. All rights reserved.<br><br>This article is protected by copyright. All rights reserved.<p /> <p>Language: en</p>",
language="en",
issn="1470-0328",
doi="10.1111/1471-0528.15118",
url="http://dx.doi.org/10.1111/1471-0528.15118"
}